Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice-Reference-Cited by-同舟云学术

Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice

Published:2019 Issue:1 Volume:7 Page:115-134
ISSN:2352-345X
Container-title:Cellular and Molecular Gastroenterology and Hepatology
language:en
Short-container-title:Cellular and Molecular Gastroenterology and Hepatology

Author:

Nishina Sohji,Yamauchi Akira^ORCID,Kawaguchi Takumi^ORCID,Kaku Kohei,Goto Moritaka^ORCID,Sasaki Kyo,Hara Yuichi,Tomiyama Yasuyuki,Kuribayashi Futoshi,Torimura Takuji,Hino Keisuke^ORCID

Funder

Keisuke Hino

Japan Society for the Promotion of Science and the Research Program on Hepatitis

Japan Agency for Medical Research and Development

Sohji Nishina

Japan Society for the Promotion of Science and Kawasaki Medical School Research Project

Akira Yamauchi

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012;White;Gastroenterology,2017

2. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice;Singal;Clin Gastroenterol Hepatol,2015

3. Diabetes and cirrhosis are risk factors for hepatocellular carcinoma after successful treatment of chronic hepatitis C;Hedenstierna;Clin Infect Dis,2016

4. Risk of hepatocellular carcinoma after sustained virological response in veterans with hepatitis C virus infection;EI-Serag;Hepatology,2016

5. Diabetes and cancer;Giovannucci;Diabetes Care,2010

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4;Clinical Nutrition;2024-08

2. NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity;Biomedicines;2024-07-25

3. G protein‐coupled receptor‐mediated signaling of immunomodulation in tumor progression;The FASEB Journal;2024-07-17

4. Lower Risks of New-Onset Hepatocellular Carcinoma in Patients With Type 2 Diabetes Mellitus Treated With SGLT2 Inhibitors Versus DPP4 Inhibitors;Journal of the National Comprehensive Cancer Network;2024-06

5. Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis;Journal of Biological Chemistry;2024-06